LUNG / Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates

Pulmonx Corporation (NASDAQ:LUNG ) Q2 2023 Earnings Conference Call August 2, 2023 4:30 PM ET Company Participants Dorothy Morgan - Investor Relations more_horizontal

REDWOOD CITY, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive trea more_horizontal

REDWOOD CITY, Calif., July 19, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive trea more_horizontal

Pulmonx Corporation (NASDAQ:LUNG ) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Laine Morgan - Investor Relations Glen more_horizontal

Pulmonx Corporation (LUNG) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to more_horizontal

Though common sense tells us to load up on securities with established track records, the concept of Nasdaq small-cap stocks to buy invariably deliver more_horizontal

Pulmonx Corporation. (NASDAQ:LUNG ) Q4 2022 Earnings Conference Call February 22, 2023 4:30 PM ET Company Participants Laine Morgan - Investor Relatio more_horizontal

Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of 7.32% and 11.27%, respectively, for the quarter ended December 2022. Do the num more_horizontal